ARCHIVES

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

This article is from The Cancer Letter archive.

Vol. 34 No. 46 | December 19, 2008

Download PDF Visit The Full Archive

Related Articles

Rituximab After CVP Improves Progression-Free Survival

March 27, 2009

In Brief: NCI Tells Cooperative Groups To Submit applications For Extra Multimodality Funds

November 28, 1975

PDF file includes 8-page February issue of Business & Regulatory Report.

February 27, 2004

NCI Treatment Division To Recompete $10 Million In Resource Contracts; Board Okays New Projects

November 12, 1976

In Brief: Congressmen Press Or More Exploratory Grant Money: Murphy Reelected By UICC

August 6, 1976

Tamoxifen: No Mortality Benefit For Most “High Risk” Women

September 29, 2006